Drug Trial Radar · NCT00419263
Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.
Last checked: Nov 20, 2026Latest source record: Feb 12, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
344
Actual
Start
Jan 2007
Primary completion
Sep 2007
Study completion Sep 2007
Sponsor
- Lead sponsor
- BioCryst PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jan 8, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study for patients with flu who also have a fever as well as other flu symptoms. Patients must have had symptoms for less than 48 hours in order to participate. Patients will have two out of three chances of getting an active study treatment and the other third will receive a placebo (dummy drug). Nobody will know who gets the active drug and who gets the inactive drug. All patients will get supplies to treat symptoms of flu. Patients will need to be seen 5 more times after they are enrolled in the study.
Conditions
- Influenza
Interventions
Peramivir 150 mgDrug
Single dose administered as bilateral 2-mL intramuscular injections in each gluteal muscle (one injection of peramivir 150 mg and one injection of placebo).
Peramivir 300 mgDrug
Single dose administered as bilateral 2-mL intramuscular injections in each gluteal muscle (2 injections of peramivir 150 mg).
PlaceboDrug
Single dose administered as bilateral 2-mL intramuscular injections in each gluteal muscle (2 injections of placebo).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Alleviation of Symptoms (Kaplan-Meier Estimate)Time frame: Up to 14 days
Locations
69 sites in 2 countries. Site status is shown where the registry gives one.
Radiant Research
Birmingham, Alabama
Clopton Clinic
Jonesboro, Arkansas
Advanced Clinical Research Institute
Anaheim, California
Orange County Clinical Trials
Anaheim, California
Medical Center
Carmichael, California
Pacific Sleep Medicines Service
El Centro, California
Advanced Clinical Research Institute
Orange, California
Benchmark Research
Sacramento, California
Pacific Sleep Medicine Services
San Diego, California
Pacific Sleep Medicine Services
San Francisco, California
Alpine Clinical Research Center
Boulder, Colorado
George Washington Unviersity
Washington D.C., District of Columbia
Clinical Research of Southern Florida
Coral Gables, Florida
University Clinical Research-Deland, LLC
DeLand, Florida
Florida Medical Research Institute
Gainesville, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
Clinical Research Center
Sarasota, Florida
Palm Beach Research Center
West Palm Beach, Florida
Georgia Clinical Research
Atlanta, Georgia
Wishard Hospital
Indianapolis, Indiana
Radiant Research
Overland Park, Kansas
Kentucky Pediatric / Adult Research
Bardstown, Kentucky
Central Kentucky Research Assoc, Inc
Lexington, Kentucky
Benchmark Research
Metairie, Louisiana
Radiant Research, Minneapolis
Edina, Minnesota
Barnes-Jewish Hospital Emergency Department
St Louis, Missouri
Medex Healthcare Research, Inc.
St Louis, Missouri
Radiant Research
St Louis, Missouri
Bozeman Urgent Care Center
Bozeman, Montana
Alliance Medical Center
Alliance, Nebraska
Midwest Family Physicians
Omaha, Nebraska
UMDNJ
Cherry Hill, New Jersey
Pulmonary & Critical Care Associates
East Brunswick, New Jersey
Brooklyn Hospital Center
Brooklyn, New York
Wake Research Associates, LLC
Raleigh, North Carolina
Summa Health
Akron, Ohio
Sterling Research Group, LTD.
Cincinnati, Ohio
Integrated Medical Research, PC
Ashland, Oregon
Research Across America at Oyster Point Family Health Center
Lancaster, Pennsylvania
Showing 40 of 69 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.